The BRIDGE – Translational Excellence Programme is again searching for mentor teams who want to combine their research and perspectives from the clinical and academic world, and develop a two-year research project together with a young researcher. In the upcoming
Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.
MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.
If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.
During the first six months of the year Lund-based SmiLe incubator companies have taken in SEK 85 million, which is 25 percent more than during all of 2018. Taken together, all SmiLe companies – 20 incubator companies and around 50
In the Greater Copenhagen-region also known as Medicon Valley, when it relates to life science specifically, life science is one of the key growth industries identified by regional as well as national politicians. On top of well-established scientific strongholds within
The chairman of Medicon Valley Alliance, Søren Bregenholt´s quarterly business column in Copenhagen Post “The Valley of Life: All for one and one for all” has just been published. Read why MVA thinks life science in the Nordics in general
9th of June applications will open for this year´s edition of Synapse – Life Science Connect´s attractive Biobusiness Summer School. If you are a life science student interested in the business side of the industry and would like to know
An opinion piece in the Swedish regional daily, Sydsvenskan, by regional politicians Elisabet Babic (Sweden), Lars Birger Salvesen (Norway) and Claus Kjeldsen (Denmark) highlights the ReproUnion project as a succesful example of collaboration across borders. The piece was also published
As one of the top priorities of the national Danish National life Science strategy, the initiaive, Trial Nation, which offers a single, national entry point for global companies, patient organisations and clinical researchers wishing to conduct clinical trials in Denmark,
2cureX AB invites shareholders and the public to attend an investor meeting in Stockholm. The company will present the ongoing operations, the way forward for 2cureX and the offer for the company’s ongoing rights issue. The investor meeting is held
At yesterday´s ordinary general meeting, MVA CEO Petter Hartman, highlighted some of the key challenges and succes stories from 2018, including the fact that the MVA-family had the pleasure of welcoming 48 new members and saw a 20% increase in